AUSTIN –Texas Attorney General Ken Paxton has announced a $63 million statewide opioid settlement with Endo Pharmaceuticals.
The agreement will largely track the terms of the Global Prescription Opioid Litigation Settlement Agreement that was announced on July 23, 2021, a press release states.
Pursuant to the settlement, Endo will pay $63 million into the Texas State Qualified Settlement Fund, without any requirement that the global deal first be finalized, and without any rebates or reductions to the payment amount.
This is the third statewide opioid settlement Attorney General Paxton has secured for Texas. In addition to the funds from Endo, Johnson & Johnson and McKinsey, Texas is also slated to receive up to $1.2 billion from distributors in the coming months.
“This settlement is the result of my office aggressively working to hold opioid manufacturers accountable for their deceptive marketing of highly-addictive pain pills, which spurred an epidemic and left victims and families with unimaginable consequences,” Paxton said.
“This settlement is a necessary step in the right direction, and we will continue to fight to heal our state from this devastating crisis.”